Tianjin TEDA Biomedical Engineering : POSTPONEMENT OF BOARD MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

天津泰達生物醫學工程股份有限公司

Tianjin TEDA Biomedical Engineering Company Limited

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 8189) POSTPONEMENT OF BOARD MEETING

The board of directors (the "Board") of Tianjin TEDA Biomedical Engineering Company Limited (the "Company") refers to the announcement issued by the Company dated 20 July 2017 in relation to the convening of a meeting of the Board (the "Board Meeting") on Tuesday, 8 August 2017 for the purposes of, among others, considering and approving the half-yearly unaudited results of the Company and its subsidiaries for the six months ended 30 June 2017 (the "2017 Interim Results") and its publication, and considering the payment of interim dividend, if any.

As more time is required to finalize the 2017 Interim Results, the Board hereby announces that the Board Meeting will be postponed from Tuesday, 8 August 2017 to Friday, 11 August 2017.

By order of the Board

Tianjin TEDA Biomedical Engineering Company Limited Sun Li

Chairman

Tianjin, the People's Republic of China 4 August 2017

As at the date of this announcement, the executive Directors of the Company are Sun Li, Hao Zhihui and Liu Renmu; the non-executive Directors of the Company are Feng Enqing, Chen Yingzhong and Li Ximing; the independent non-executive Directors of the Company are Li Xudong, Duan Zhongpeng and Gao Chun.

This announcement, for which the directors are willing to collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief that the information contained in this announcement is accurate and complete in all material respects and is not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

The announcement will remain at the "Latest Company Announcements" page on the GEM website at www.hkgem.com for at least seven (7) days from the date of its posting, and it will also be published and remain on the website of the Company at www.bioteda.com